1005206-16-5

Basic information

• Product Name: 4-Cyano-7H-Pyrrolo[2,3-d]pyrimidine
• Synonyms: 4-Cyano-7H-Pyrrolo[2,3-d]pyrimidine;7H-Pyrrolo[2,3-d]pyriMidine-4-carbonitrile
• CAS NO: 1005206-16-5
• Molecular Formula: C₇H₄N₄
• Molecular Weight: 144.13346
• Mol File: 1005206-16-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.44
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 10.25±0.50(Predicted)
• CAS DataBase Reference: 4-Cyano-7H-Pyrrolo[2,3-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Cyano-7H-Pyrrolo[2,3-d]pyrimidine(1005206-16-5)
• EPA Substance Registry System: 4-Cyano-7H-Pyrrolo[2,3-d]pyrimidine(1005206-16-5)

Safety Data

• Hazardous Substances Data: 1005206-16-5(Hazardous Substances Data)

Usage

General Description

4-Cyano-7H-Pyrrolo[2,3-d]pyrimidine, also known as CPP, is a chemical compound with a molecular formula of C7H4N4. It is a heterocyclic organic compound that consists of a pyrrolopyrimidine core with a cyano group attached at the 4th position. CPP is commonly used in the research and development of pharmaceuticals and other organic compounds. It is known for its potential antimicrobial and antiviral properties, as well as its ability to modulate ion channels and receptors in the central nervous system. Additionally, it is used as a precursor in organic synthesis to produce more complex chemical structures. Due to its unique structure and versatile properties, CPP has shown potential in various medicinal and industrial applications.

InChI:InChI=1S/C7H4N4/c8-3-6-5-1-2-9-7(5)11-4-10-6/h1-2,4H,(H,9,10,11)

Upstream product

• 1086423-55-3 7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidine-4-carbonitrile 
• 151-50-8 potassium cyanide 
• 3680-69-1 4-chloro-1H-pyrrolo[2,3-d]pyrimidine 

Downstream Products

• 1168106-92-0 5-bromo-7H-pyrrolo[2,3-d]pyrimidine-4-carbonitrile 
• 1086423-57-5 7-(toluene-4-sulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-4-carboxylic acid [2-methyl-5-(3-trifluoromethyl-phenylcarbamoyl)-phenyl]-amide 
• 1086423-54-2 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylic acid [2-methyl-5-(3-trifluoromethyl-phenylcarbamoyl)-phenyl]-amide 
• 1086423-56-4 7-(toluene-4-sulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-4-carboxylic acid 
• 1086423-55-3 7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidine-4-carbonitrile 
• 935466-96-9 C-(7H-pyrrolo[2,3d]pyrimidin-4-yl)-methylamine dihydrochloride 

Relevant articles and documents

PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.

COMPOUNDS AND METHODS OF USE

Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.